Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Unmasking the Conformational Stability and Inhibitor Binding to SARS-CoV-2 Main Protease Active Site Mutants and Miniprecursor

Journal Article · · Journal of Molecular Biology

We recently demonstrated that inhibitor binding reorganizes the oxyanion loop of a monomeric catalytic domain of SARS CoV-2 main protease (MPro) from an unwound (E) to a wound (active, E*) conformation, independent of dimerization. Here we assess the effect of the flanking N-terminal residues, to imitate the MPro precursor prior to its autoprocessing, on conformational equilibria rendering stability and inhibitor binding. Thermal denaturation (Tm) of C145A mutant, unlike H41A, increases by 6.8 °C, relative to wild-type mature dimer. An inactivating H41A mutation to maintain a miniprecursor containing TSAVL[Q or E] of the flanking nsp4 sequence in an intact form [(-6)MProH41A and (-6*)MProH41A, respectively], and its corresponding mature MProH41A were systematically examined. While the H41A mutation exerts negligible effect on Tm and dimer dissociation constant (Kdimer) of MProH41A, relative to the wild type MPro, both miniprecursors show a 4–5 °C decrease in Tm and > 85-fold increase in Kdimer as compared to MProH41A. The Kd for the binding of the covalent inhibitor GC373 to (-6*)MProH41A increases ~12-fold, relative to MProH41A, concomitant with its dimerization. While the inhibitor-free dimer exhibits a state in transit from E to E* with a conformational asymmetry of the protomers’ oxyanion loops and helical domains, inhibitor binding restores the asymmetry to mature-like oxyanion loop conformations (E*) but not of the helical domains. Finally, disorder of the terminal residues 1–2 and 302–306 observed in both structures suggest that N-terminal autoprocessing is tightly coupled to the E-E* equilibrium and stable dimer formation.

Research Organization:
Oak Ridge National Laboratory (ORNL), Oak Ridge, TN (United States); Oak Ridge National Lab. (ORNL), Oak Ridge, TN (United States). Spallation Neutron Source (SNS); Oak Ridge National Lab. (ORNL), Oak Ridge, TN (United States). High Flux Isotope Reactor (HFIR)
Sponsoring Organization:
USDOE; USDOE Office of Science (SC), Basic Energy Sciences (BES); USDOE Office of Science (SC), Biological and Environmental Research (BER); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institutes of Health (NIH)
Grant/Contract Number:
AC05-00OR22725
OSTI ID:
1898984
Journal Information:
Journal of Molecular Biology, Journal Name: Journal of Molecular Biology Journal Issue: 24 Vol. 434; ISSN 0022-2836
Publisher:
ElsevierCopyright Statement
Country of Publication:
United States
Language:
English

References (48)

A Quick Route to Multiple Highly Potent SARS‐CoV‐2 Main Protease Inhibitors** journal December 2020
The establishment of reference sequence for SARS‐CoV‐2 and variation analysis journal March 2020
Current developments in Coot for macromolecular model building of Electron Cryo‐microscopy and Crystallographic Data journal March 2020
The Proteins of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2 or n-COV19), the Cause of COVID-19 journal May 2020
Liberation of SARS-CoV main protease from the viral polyprotein: N-terminal autocleavage does not depend on the mature dimerization mode journal January 2010
Activation and maturation of SARS-CoV main protease journal April 2011
On the analysis of protein self-association by sedimentation velocity analytical ultracentrifugation journal September 2003
Size-Distribution Analysis of Macromolecules by Sedimentation Velocity Ultracentrifugation and Lamm Equation Modeling journal March 2000
Analytical Ultracentrifugation: Sedimentation Velocity and Sedimentation Equilibrium book January 2008
Calculations and Publication-Quality Illustrations for Analytical Ultracentrifugation Data book January 2015
The substrate specificity of SARS coronavirus 3C-like proteinase journal April 2005
Mutation of Glu-166 Blocks the Substrate-Induced Dimerization of SARS Coronavirus Main Protease journal April 2010
A Crystallographic Snapshot of SARS-CoV-2 Main Protease Maturation Process journal September 2021
Two adjacent mutations on the dimer interface of SARS coronavirus 3C-like protease cause different conformational changes in crystal structure journal June 2009
Expedited Approach toward the Rational Design of Noncovalent SARS-CoV-2 Main Protease Inhibitors journal April 2021
3CL Protease Inhibitors with an Electrophilic Arylketone Moiety as Anti-SARS-CoV-2 Agents journal July 2021
Structural, Electronic, and Electrostatic Determinants for Inhibitor Binding to Subsites S1 and S2 in SARS-CoV-2 Main Protease journal October 2021
Small-Molecule Thioesters as SARS-CoV-2 Main Protease Inhibitors: Enzyme Inhibition, Structure–Activity Relationships, Antiviral Activity, and X-ray Structure Determination journal June 2022
Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy journal May 2020
Identification of 14 Known Drugs as Inhibitors of the Main Protease of SARS-CoV-2 journal October 2020
Identification of Novel Inhibitors of the SARS Coronavirus Main Protease 3CLpro journal March 2004
Structural plasticity of SARS-CoV-2 3CL Mpro active site cavity revealed by room temperature X-ray crystallography journal June 2020
Crystallographic structure of wild-type SARS-CoV-2 main protease acyl-enzyme intermediate with physiological C-terminal autoprocessing site journal November 2020
Covalent narlaprevir- and boceprevir-derived hybrid inhibitors of SARS-CoV-2 main protease journal April 2022
Coronavirus biology and replication: implications for SARS-CoV-2 journal October 2020
A new coronavirus associated with human respiratory disease in China journal February 2020
Modulation of the monomer-dimer equilibrium and catalytic activity of SARS-CoV-2 main protease by a transition-state analog inhibitor journal March 2022
Autoprocessing and oxyanion loop reorganization upon GC373 and nirmatrelvir binding of monomeric SARS-CoV-2 main protease catalytic domain journal September 2022
Inhibition of autoprocessing of natural variants and multidrug resistant mutant precursors of HIV-1 protease by clinical inhibitors journal May 2011
SARS-CoV 3CL protease cleaves its C-terminal autoprocessing site by novel subsite cooperativity journal October 2016
Unusual zwitterionic catalytic site of SARS–CoV-2 main protease revealed by neutron crystallography journal October 2020
Maturation Mechanism of Severe Acute Respiratory Syndrome (SARS) Coronavirus 3C-like Proteinase journal May 2010
Mechanism of the Maturation Process of SARS-CoV 3CL Protease journal March 2005
Mutation of Gly-11 on the Dimer Interface Results in the Complete Crystallographic Dimer Dissociation of Severe Acute Respiratory Syndrome Coronavirus 3C-like Protease journal January 2008
Effect of the Active Site D25N Mutation on the Structure, Stability, and Ligand Binding of the Mature HIV-1 Protease journal May 2008
Phaser crystallographic software journal July 2007
electronic Ligand Builder and Optimization Workbench ( eLBOW ): a tool for ligand coordinate and restraint generation journal September 2009
MolProbity : all-atom structure validation for macromolecular crystallography journal December 2009
Overview of the CCP 4 suite and current developments journal March 2011
How good are my data and what is the resolution? journal June 2013
Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix journal October 2019
Autoprocessing mechanism of severe acute respiratory syndrome coronavirus 3C-like protease (SARS-CoV 3CL pro ) from its polyproteins journal March 2013
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors journal March 2020
SARS-CoV-2 M pro inhibitors with antiviral activity in a transgenic mouse model journal February 2021
Mechanism for Controlling the Dimer-Monomer Switch and Coupling Dimerization to Catalysis of the Severe Acute Respiratory Syndrome Coronavirus 3C-Like Protease journal February 2008
Molecular mechanisms of severe acute respiratory syndrome (SARS) journal January 2005
A drug repurposing screen identifies hepatitis C antivirals as inhibitors of the SARS-CoV2 main protease journal February 2021
Structural Characterization of SARS-CoV-2: Where We Are, and Where We Need to Be journal December 2020